Adial Pharmaceuticals- Warrants (31/07/2023) Total Current Liabilities

As of the most recent data (June 2026), ADILW shows a total current liabilities of $5.1M. That compares with $1.2M in the prior-year period — up 322.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADILW's total current liabilities is now $5.1M (was $1.2M) — a 322.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adial Pharmaceuticals- Warrants (31/07/2023) is outperforming or lagging.

Tracking ADILW's total current liabilities over time shows whether Adial Pharmaceuticals- Warrants (31/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.1M That compares with $1.2M in the prior-year period — up 322.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $5.1M) with ownership activity and broader fundamentals.

Adial Pharmaceuticals- Warrants (31/07/2023)'s total current liabilities is $5.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.